This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2 AH Lichtenstein , LJ Appel , M Brands , (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114, 82–96.
3 CJ Lavie , RV Milani , MR Mehra , (2009) Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 54, 585–594.
5 ND Riediger , RA Othman , M Suh , (2009) A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 109, 668–679.
6 KB Filion , F El Khoury , M Bielinski , (2010) Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 10, 24.
7 AR Jadad , RA Moore , D Carroll , (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17, 1–12.
8 GJ Dehmer , JJ Popma , EK van den Berg , (1988) Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 319, 733–740.
9 ER Nye , MB Ablett , MC Robertson , (1990) Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty. Aust N Z J Med 20, 549–552.
10 I Bairati , L Roy & F Meyer (1992) Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 85, 950–956.
11 A Leaf , MB Jorgensen , AK Jacobs , (1994) Do fish oils prevent restenosis after coronary angioplasty? Circulation 90, 2248–2257.
13 J Eritsland , H Arnesen , K Gronseth , (1996) Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 77, 31–36.
16 O Johansen , M Brekke , I Seljeflot , (1999) N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol 33, 1619–1626.
19 ML Burr , PA Ashfield-Watt , FD Dunstan , (2003) Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 57, 193–200.
20 A Leaf , CM Albert , M Josephson , (2005) Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 112, 2762–2768.
21 MH Raitt , WE Connor , C Morris , (2005) Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 293, 2884–2891.
22 IA Brouwer , PL Zock , AJ Camm , (2006) Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 295, 2613–2619.
24 HFI Gissi , L Tavazzi , AP Maggioni , (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372, 1223–1230.
28 S Nodari , M Triggiani , U Campia , (2011) Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol 57, 870–879.
30 C von Schacky & WS Harris (2007) Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 73, 310–315.
32 PE Marik & J Varon (2009) Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 32, 365–372.
33 P Saravanan , NC Davidson , EB Schmidt , (2010) Cardiovascular effects of marine omega-3 fatty acids. Lancet 376, 540–550.
36 C White (2005) Suspected research fraud: difficulties of getting at the truth. BMJ 331, 281–288.
37 H Iso , M Kobayashi , J Ishihara , (2006) Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 113, 195–202.
38 N Watanabe , Y Watanabe , M Kumagai , (2009) Administration of dietary fish oil capsules in healthy middle-aged Japanese men with a high level of fish consumption. Int J Food Sci Nutr 60, Suppl. 5, 136–142.
39 H Origasa , M Yokoyama , M Matsuzaki , (2010) Clinical importance of adherence to treatment with eicosapentaenoic acid by patients with hypercholesterolemia. Circ J 74, 510–517.
41 P Perez-Martinez , J Delgado-Lista , F Perez-Jimenez , (2010) Update on genetics of postprandial lipemia. Atheroscler Suppl 11, 39–43.
42 TM Teslovich , K Musunuru , AV Smith , (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713.
43 H Pishva , SA Mahboob , P Mehdipour , (2010) Fatty acid-binding protein-2 genotype influences lipid and lipoprotein response to eicosapentaenoic acid supplementation in hypertriglyceridemic subjects. Nutrition 26, 1117–1121.
44 E Olano-Martin , E Anil , MJ Caslake , (2010) Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. Atherosclerosis 209, 104–110.
47 F Thies , JM Garry , P Yaqoob , (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361, 477–485.
48 WS Harris , M Miller , AP Tighe , (2008) Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 197, 12–24.
49 CN Serhan , N Chiang & TE Van Dyke (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8, 349–361.
52 D Mozaffarian , BM Psaty , EB Rimm , (2004) Fish intake and risk of incident atrial fibrillation. Circulation 110, 368–373.
54 P Saravanan , B Bridgewater , AL West , (2010) Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol 3, 46–53.
55 IA Brouwer , MH Raitt , C Dullemeijer , (2009) Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J 30, 820–826.
56 AO Verkerk , AC van Ginneken , G Berecki , (2006) Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovasc Res 70, 509–520.
57 R Coronel , FJ Wilms-Schopman , HM Den Ruijter , (2007) Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts. Cardiovasc Res 73, 386–394.
59 S Chalupka (2009) Omega-3 polyunsaturated fatty acid in primary and secondary cardiovascular disease prevention. AAOHN J 57, 480.
61 SD Kristensen , AM Iversen & EB Schmidt (2001) n-3 polyunsaturated fatty acids and coronary thrombosis. Lipids 36, S79–S82.
63 PD Watson , PS Joy , C Nkonde , (2009) Comparison of bleeding complications with omega-3 fatty acids+aspirin+clopidogrel–versus–aspirin+clopidogrel in patients with cardiovascular disease. Am J Cardiol 104, 1052–1054.
64 K Park & D Mozaffarian (2010) Omega-3 fatty acids, mercury, and selenium in fish and the risk of cardiovascular diseases. Curr Atheroscler Rep 12, 414–422.
66 MF Hau , AH Smelt , AJ Bindels , (1996) Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol 16, 1197–1202.
73 GC Leng , GS Taylor , AJ Lee , (1999) Essential fatty acids and cardiovascular disease: the Edinburgh Artery Study. Vasc Med 4, 219–226.